Clinical Trial Update: Effect of GSK1399686 in Patients With Mild to Moderately Active Ulcerative Colitis [Phase 2]

View source ↗

Summary

Phase 2 trial results for GSK1399686 in mild to moderately active ulcerative colitis have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colitis
• Ulcerative Colitis

Drugs mentioned

• GSK1399686

Snippet

Sponsor: GlaxoSmithKline | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED | Results posted: 2017-06-26